Revium Rx. (RVRC) Form 8-K — Jun 22, 2026
Ms. Inna Martin resigned from her positions as Director, Chief Operating Officer, and President of Revium Rx. effective immediately on June 16, 2026. The resignation was attributed to differences in expectations between Ms.
Key figures
- Options Shares
- 2440000
- Employment Termination Date
- 2026-09-10
- Options Extended Exercise Deadline
- 2028-09-30
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.